Skip to main content
SpringerLink
Log in

Guidelines on Radioisotope Treatment of Liver Cancer and Liver Metastases with Intra-arterial Radioactive Compounds

  • Chapter
  • First Online:
Clinical Applications of Nuclear Medicine Targeted Therapy

  • 991 Accesses

Abstract

The present chapter has the aim to provide the current position of radioembolization (RE) for the treatment of primary and secondary liver lesions, in the main national and international clinical guidelines. In Table 16.1, a summary of clinical indications is reported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251–78.

    Article  PubMed  Google Scholar 

  2. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13–23.

    Article  PubMed  Google Scholar 

  3. Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2011;38(7):1393–406. https://doi.org/10.1007/s00259-011-1812-2.

    Article  CAS  PubMed  Google Scholar 

  4. Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, et al. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol. 2011;22:265–78.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.

    Article  Google Scholar 

  7. Verslype C, Rosmorduc O, Rougier P. Hepatocellular carcinoma: ESMO-ESDO clinical practice guidelines. Ann Oncol. 2012;23:vii41–8.

    Article  PubMed  Google Scholar 

  8. Boily G, Villeneuve J-P, Lacoursière L, Chaudhury P, Couture F, Ouellet J-F, et al. Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations. HPB (Oxford). 2015;17:52–65.

    Article  Google Scholar 

  9. Kennedy A, Bester L, Salem R, Sharma RA, Parks RW, Ruszniewski F. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference. HPB (Oxford). 2015;17:29–37.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Murat Fani Bozkurt

  2. Veneto Institute of Oncology IOV – IRCCS, Padua, Italy

    Laura Evangelista

Authors
  1. Murat Fani Bozkurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Evangelista
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murat Fani Bozkurt .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Humanitas Gavazzeni Hospital, Bergamo, Italy

    Emilio Bombardieri

  2. Nuclear Medicine Therapy and Endocrinology, Istituto Nazionale dei Tumori, Milano, Italy

    Ettore Seregni

  3. Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy

    Laura Evangelista

  4. Nuclear Medicine Division, Istituto Nazionale dei Tumori, Milano, Italy

    Carlo Chiesa

  5. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Arturo Chiti

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bozkurt, M.F., Evangelista, L. (2018). Guidelines on Radioisotope Treatment of Liver Cancer and Liver Metastases with Intra-arterial Radioactive Compounds. In: Bombardieri, E., Seregni, E., Evangelista, L., Chiesa, C., Chiti, A. (eds) Clinical Applications of Nuclear Medicine Targeted Therapy . Springer, Cham. https://doi.org/10.1007/978-3-319-63067-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63067-0_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63066-3

  • Online ISBN: 978-3-319-63067-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation